Innovotech, Inc. (IOT.V)
0.065
0.00 (0.00%)
CAD |
TSXV |
Oct 13, 16:00
Innovotech Net Income (Quarterly) : -0.6557M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6557M |
| March 31, 2026 | -0.4013M |
| December 31, 2025 | 0.1723M |
| September 30, 2025 | 0.0929M |
| June 30, 2025 | -0.2412M |
| March 31, 2025 | 0.0635M |
| December 31, 2024 | 0.4531M |
| September 30, 2024 | -0.0213M |
| June 30, 2024 | -0.1148M |
| March 31, 2024 | -0.1022M |
| December 31, 2023 | -0.0299M |
| September 30, 2023 | -0.1175M |
| June 30, 2023 | 0.0729M |
| March 31, 2023 | -0.083M |
| December 31, 2022 | -0.0834M |
| September 30, 2022 | 0.0417M |
| June 30, 2022 | -0.0625M |
| March 31, 2022 | -0.0323M |
| December 31, 2021 | 0.2027M |
| September 30, 2021 | -0.0215M |
| June 30, 2021 | 0.1637M |
| March 31, 2021 | 0.0222M |
| December 31, 2020 | 0.0064M |
| September 30, 2020 | 0.0932M |
| June 30, 2020 | 0.122M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.1153M |
| December 31, 2019 | -0.0444M |
| September 30, 2019 | 0.0152M |
| June 30, 2019 | -0.005M |
| March 31, 2019 | -0.0145M |
| December 31, 2018 | 0.0318M |
| September 30, 2018 | -0.0168M |
| June 30, 2018 | -0.0662M |
| March 31, 2018 | |
| December 31, 2017 | 0.0293M |
| September 30, 2017 | 0.6843M |
| June 30, 2017 | -0.0264M |
| March 31, 2017 | 0.0661M |
| December 31, 2016 | -0.1375M |
| September 30, 2016 | 0.0364M |
| June 30, 2016 | -0.0688M |
| March 31, 2016 | -0.0456M |
| December 31, 2015 | -0.0501M |
| September 30, 2015 | -0.0471M |
| June 30, 2015 | -0.093M |
| March 31, 2015 | -0.0604M |
| December 31, 2014 | 0.1616M |
| September 30, 2014 | -0.133M |
| June 30, 2014 | -0.1089M |
| March 31, 2014 | -0.1294M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arch Biopartners, Inc. | -0.4751M |
| Kane Biotech, Inc. | -0.8336M |
| Quest PharmaTech, Inc. | 3.401M |
| BriaCell Therapeutics Corp. | -9.920M |
| Vaxil Bio Ltd. | -0.064M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.6798M |
| Total Expenses (Quarterly) | 1.334M |
| EPS Diluted (Quarterly) | -0.012 |
| Enterprise Value | 3.375M |
| Gross Profit Margin (Quarterly) | 8.55% |
| Profit Margin (Quarterly) | -96.45% |
| Earnings Yield | -22.00% |
| Normalized Earnings Yield | -22.92 |